BRIEF-Axsome Therapeutics announces AXS-06 meets primary endpoint in phase 1 clinical trial
July 25, 2017 at 07:56 AM EDT
* Axsome Therapeutics announces AXS-06 (moseic meloxicam and esomeprazole) meets primary endpoint in phase 1 clinical trial